Marit Synnestvedt

Persistence of Disseminated Tumor Cells in the Bone Marrow of Breast Cancer Patients Predicts Increased Risk for Relapse—A European Pooled Analysis

Wolfgang Janni, Florian D. Vogl, Gro Wiedswang et al. · Clinical Cancer Research · 2011 · 246 citations

Medicine, Oncology, Breast Oncology +15

DNA methylation patterns in luminal breast cancers differ from non‐luminal subtypes and can identify relapse risk independent of other clinical variables

Sitharthan Kamalakaran, Vinay Varadan, Hege Russnes et al. · Molecular Oncology · 2010 · 148 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

Presence of bone marrow micrometastasis is associated with different recurrence risk within molecular subtypes of breast cancer

Bjørn Naume, Xi Zhao, Marit Synnestvedt et al. · Molecular Oncology · 2007 · 145 citations · Full text

Medicine, Oncology, Pathology +16

NR2F1 stratifies dormant disseminated tumor cells in breast cancer patients

Elin Borgen, M.C. Rypdal, María Soledad Sosa et al. · Breast Cancer Research · 2018 · 116 citations · Full text

Medicine, Cell Biology, Oncology +16

Clinical Outcome With Correlation to Disseminated Tumor Cell (DTC) Status After DTC-Guided Secondary Adjuvant Treatment With Docetaxel in Early Breast Cancer

Bjørn Naume, Marit Synnestvedt, Ragnhild Sørum Falk et al. · Journal of Clinical Oncology · 2014 · 89 citations · Full text

Medicine, Oncology, Pharmacotherapy +17